Possibilities of diagnosis exacerbations of chronic obstructive pulmonary disease in clinical practice: the conclusion of the expert council of the Far Eastern and Siberian Federal Districts
https://doi.org/10.17238/PmJ1609-1175.2017.4.25-30
Abstract
Exacerbations of chronic obstructive pulmonary disease (COPD) are one of the factors determining the prognosis for patients with this disease. There is a hypodiagnosis of exacerbations of COPD in clinical practice, about 50% of which are not detected or not fixed by doctors, are often underestimated by the patients themselves. The need for correction of the prescribed basic therapy depending on the frequency and severity of exacerbations requires the availability of convenient, accurate and easy-to-use tools for the diagnosis of this condition. The existing variants of the questionnaires for identifying the preceding and current exacerbations are diverse and have a number of characteristics. The article contains data on existing instruments for the diagnosis of exacerbations, and also suggests a number of questions aimed at their retrospective detection. A reminder for patients with information on the role and manifestations of exacerbations of COPD, as well as actions in cases of their presence, is offered.
About the Authors
S. N. Avdeev
Research Institute of Pulmonology, FMBA Russia
Russian Federation
Russian Federation
V. A. Nevzorova
Pacific State Medical University
Russian Federation
Russian Federation
M. F. Kinyaykin
Pacific State Medical University
Russian Federation
Russian Federation
L. M. Kudelya
Novosibirsk State Medical University
Russian Federation
Russian Federation
O. V. Molchanova
Institute for Advanced Training of Health Professionals
Russian Federation
Russian Federation
I. V. Helimskaya
Far Eastern State Medical University
Russian Federation
Russian Federation
I. V. Demko
Krasnoyarsk State Medical University named after V.F. Voino-Yasenetsky
Russian Federation
Russian Federation
Yu. N. Krasnova
Irkutsk State Medical Academy of Postgraduate Education
Russian Federation
Russian Federation
N. V. Lareva
Chita State Medical Academy
Russian Federation
Russian Federation
N. S. Gyrgeshkinova
Republican Clinical Hospital named after N.A. Semashko
Russian Federation
Russian Federation
References
1. Хроническая обструктивная болезнь легких: клинические рекомендации. М.: МЗ РФ, 2016. 68 с
2. Brightling C.E. Biomarkers that predict and guide therapy for exacerbations of chronic obstructive pulmonary disease // Ann. Am. Thorac. 2013. Vol. 10 (Suppl.). P. 214-219.
3. Buhl R., Criee C.P., Kardos P. [et al.]. A year in the life of German patients with COPD: the DACCORD observational study // Intern. J. COPD. 2016. Vol. 11. P. 1639-1646.
4. Calle Rubio M., Alcazar Navarrete B., Soriano J.B. [et al.]. Clinical audit of COPD in outpatient respiratory clinics in Spain: the EPOCONSUL study // Int. J. Chron. Obstruct. Pulmon. Dis. 2017. Vol. 12. P. 417-426.
5. Cote J., Cartier A., Malo J.L. [et al.]. Compliance with peak expiratory flow monitoring in home management of asthma // Chest. 1998. Vol. 113, No. 4. P. 968-972.
6. DeVries R., Kriebel D., Sama S. Validation of the breathlessness, cough and sputum scale to predict COPD exacerbation // NPJ Prim. Care Respir. Med. 2016. Vol. 1, No. 26. P. 1-3.
7. From the global strategy for the diagnosis, management and prevention of COPD, Global initiative for chronic obstructive lung disease (GOLD) 2017. URL: http://goldcopd.org (date of access: 01.07.2017).
8. Groenewegen K.H., Schols A.M., Wouters E.F. Mortality and mortality related factors after hospitalization for acute exacerbation of COPD // Chest. 2003. Vol. 124. P. 459-467.
9. Hurst J.R., Vestbo J., Anzueto A. [et al.]. Susceptibility to exacerbation in chronic obstructive pulmonary disease // N. Engl. J. Med. 2010. Vol. 363, No. 12. P. 1128-1138.
10. Jones P.W., Chen W.H., Wilcox T.K. [et al.]. Characterizing and quantifying the symptomatic features of COPD exacerbations // Chest. 2011. Vol. 139, No. 6. P. 1388-1394.
11. Jones P. W., Chuecos F., Lamarca R. [et al.]. Unreported exacerbations of chronic obstructive pulmonary disease are associated with a reduction in health status: results from the ATTAIN study // Am. J. Respir. Crit. Care Med. 2013. Vol. 187. A6072.
12. Jones P.W., Lamarca R., Chuecos F. [et al.]. Characterisation and impact of reported and unreported exacerbations: results from ATTAIN // Eur. Respir. J. 2014. Vol. 44, No. 5. P. 1156-1165.
13. Langsetmo L., Platt R.W., Ernst P. [et al.]. Underreporting exacerbation of chronic obstructive pulmonary disease in a longitudinal cohort // Am. J. Respir. Crit. Care Med. 2008. Vol. 177. No. 4. P. 396-401.
14. Leidy N.K., Rennard S., Schmier J. [et al.]. The breathlessness, cough, and sputum scale: the development of empirically based guidelines for interpretation // Chest 2003. Vol. 124, No. 6. P. 2182-2191.
15. Leidy N.K., Sexton C.C., Jones P.W. et al. Measuring respiratory symptoms in clinical trials of COPD: reliability and validity of a daily diary // Thorax. 2014. Vol. 69. №5. P. 443-449.
16. Make B.J., Eriksson G., Calverley P.M. [et al.]. A score to predict short-term risk of COPD exacerbations (SCOPEX) // Int. J. COPD. 2015. Vol. 10. P. 201-209.
17. Sato M., Chubachi S., Sasaki M. [et al.]. Impact of mild exacerbation on COPD symptoms in a Japanese cohort // Int. J. Chron. Obstruct. Pulmon. Dis. 2016. Vol. 11. P. 1269-1278.
18. Seemungal T., Donaldson G.C., Bhowmik A. [et al.]. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease // Am. J. Respir. Crit. Care Med. 2000. Vol. 161. No. 5. P. 1608-1613.
19. Seemungal T.A., Donaldson G.C., Paul E.A. [et al.]. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease // Am. J. Respir. Crit. Care Med. 1998. Vol. 157. P. 1418-1422.
20. Singh D., Kampschulte J., Wedzicha J.A. [et al.]. A trial of beclomethasone/formoterol in COPD using EXACT-PRO to measure exacerbations // Eur. Respir. J. 2013. Vol. 41, No. 1. P. 12-17.
21. Soyez F., Ninot G., Herkert A. [et al.]. Validation of an evaluation questionnaire for COPD acute exacerbations (Exascore) // Revue des Maladies Respiratoires. 2016. Vol. 33, No. 1. P. 17-24.
22. Steer J., Gibson J., Bourke S.C. The DECAF Score: predicting hospital mortality in exacerbations of chronic obstructive pulmonary disease // Thorax. 2012. Vol. 67, No. 11. P. 970-976.
23. Stone A.A., Shiffman S., Schwartz J.E. [et al.]. Patient compliance with paper and electronic diaries // Control Clin. Trials. 2003. Vol. 24, No. 2. P. 182-199.
24. Stukalina E., Arkhipov V., Miravitlles M. [et al.]. The distribution of COPD categories in general practice according to GOLD 2011 classification in Russian Federation // Poster presented at American Thoracic Society Congress, San-Francisco, USA. 2016, Р5330.
25. Wedzicha J.A., Banerji D., Chapman K.R. [et al.]. Indacaterol-Glycopyrronium versus Salmeterol-Fluticasone for COPD // N. Engl. J. Med. 2016. Vol. 374. P. 2222-2234.
26. Wedzicha J.A., Seemungal T.A. COPD exacerbations: defining their cause and prevention // Lancet. 2007. Vol. 370, No. 9589. P. 786-796.
27. WHO. Chronic respiratory diseases. 2010. URL: http://www. who.int/respiratory/copd/burden/en/index (date of access: 01.07.2017).
28. WHO. COPD Fact Sheet. 2009. No. 315. URL: http://www. who.int/mediacentre/factsheets/fs315/en/index (date of access: 01.07.2017).
29. Wilkinson T.M., Donaldson G.C., Hurst J.R. [et al.]. Early therapy improves outcomes of exacerbations of chronic obstructive pulmonary disease // Am. J. Respir. Crit. Care Med. 2004. Vol. 169. P. 1298-1303.
Review
For citations:
Avdeev S.N., Nevzorova V.A., Kinyaykin M.F., Kudelya L.M., Molchanova O.V., Helimskaya I.V., Demko I.V., Krasnova Yu.N., Lareva N.V., Gyrgeshkinova N.S. Possibilities of diagnosis exacerbations of chronic obstructive pulmonary disease in clinical practice: the conclusion of the expert council of the Far Eastern and Siberian Federal Districts. Pacific Medical Journal. 2017;(4):25-30. (In Russ.) https://doi.org/10.17238/PmJ1609-1175.2017.4.25-30
Views:
304
Email this article 